Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy study of antimalarial drugs in Senegal
PACTR202003802011316Phase 3Completed
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of artesunate + amodiaquine, artemether + lumefantrine and dihydroartemisinin + piperaquine in malaria and Malaria (3 arms). Primary endpoints: Treatment efficacy and PCR-corrected recurrence classification. Started Sep 2018; status: completed.
02
Drugs
artesunate + amodiaquineartemether + lumefantrinedihydroartemisinin + piperaquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on PACTR202003802011316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202003802011316.